These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31900225)

  • 1. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy.
    Wang C; Jiang X; Li X; Song S; Meng Q; Wang L; Lu Y; Xin X; Pu H; Gui X; Li T; Lu D
    Stem Cell Res Ther; 2020 Jan; 11(1):8. PubMed ID: 31900225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a.
    Xin X; Wu M; Meng Q; Wang C; Lu Y; Yang Y; Li X; Zheng Q; Pu H; Gui X; Li T; Li J; Jia S; Lu D
    Mol Cancer; 2018 Jun; 17(1):94. PubMed ID: 29895332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
    Wang L; Li X; Zhang W; Yang Y; Meng Q; Wang C; Xin X; Jiang X; Song S; Lu Y; Pu H; Gui X; Li T; Xu J; Li J; Jia S; Lu D
    Mol Ther; 2020 Feb; 28(2):572-586. PubMed ID: 31732298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
    Wang Y; Chen F; Zhao M; Yang Z; Li J; Zhang S; Zhang W; Ye L; Zhang X
    J Biol Chem; 2017 Sep; 292(37):15395-15407. PubMed ID: 28765279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
    Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
    Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.
    Yang Y; Meng Q; Wang C; Li X; Lu Y; Xin X; Zheng Q; Lu D
    J Mol Med (Berl); 2018 Oct; 96(10):1119-1130. PubMed ID: 30140938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
    Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
    Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
    Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
    Zhang H; Liao Z; Liu F; Su C; Zhu H; Li Y; Tao R; Liang H; Zhang B; Zhang X
    Aging (Albany NY); 2019 Oct; 11(20):9111-9127. PubMed ID: 31645479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.
    Li D; Liu X; Zhou J; Hu J; Zhang D; Liu J; Qiao Y; Zhan Q
    Hepatology; 2017 May; 65(5):1612-1627. PubMed ID: 28027578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.
    Cui M; Xiao Z; Wang Y; Zheng M; Song T; Cai X; Sun B; Ye L; Zhang X
    Cancer Res; 2015 Mar; 75(5):846-57. PubMed ID: 25592151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
    Wu M; Lin Z; Li X; Xin X; An J; Zheng Q; Yang Y; Lu D
    Sci Rep; 2016 Oct; 6():36045. PubMed ID: 27782152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
    Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
    World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.
    Wang C; Li Y; Yan S; Wang H; Shao X; Xiao M; Yang B; Qin G; Kong R; Chen R; Zhang N
    Nat Commun; 2020 Jun; 11(1):3162. PubMed ID: 32572027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
    Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
    Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
    Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
    Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
    Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.